Brief: Evolva Holding: Evolva's nootkatone enters NIH-sponsored studies
July 25 (Reuters) - Evolva Holding SA EVE.S :
* Evolva's nootkatone enters NIH-sponsored studies to assess
its effectiveness against mosquitoes that transmit Zika virus
* Study will evaluate nootkatone in multiple formulations
against wild type and insecticide-resistant mosquitoes that
carry virus
Source text for Eikon: ID:nTENqycvna
Further company coverage: EVE.S
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 722 0920;))
Recent news on EvoNext Holdings SA
See all newsBrief: Evolva Holding: Shareholder Clearway Requests General Meeting
Swiss stocks - Factors to watch on April 15
Brief: Evolva Holding Says shareholders Of Evolva In Liquidation Approve Bod Proposals At AGM
Brief: Evolva And Nice & Green Agree On Improvements To Financing Agreement
Brief: Evolva Holding SA: Initiates Review Of Strategic Alternatives And Revokes Guidance